Figures & data
Figure 1 Chemical structure of EFAs. (A) ALA, α-linolenic acid. (B) EPA, eicosapentaenoic acid. (C) DHA, docosahexaenoic acid. (D) LOA, linoleic acid. (E) GLA, γ-linolenic acid. (F) AA, arachidonic acid.
![Figure 1 Chemical structure of EFAs. (A) ALA, α-linolenic acid. (B) EPA, eicosapentaenoic acid. (C) DHA, docosahexaenoic acid. (D) LOA, linoleic acid. (E) GLA, γ-linolenic acid. (F) AA, arachidonic acid.](/cms/asset/7ee09565-06e6-41ba-a594-ce8ac3390885/didr_a_373991_f0001_c.jpg)
Figure 2 The biofilm formation ability of C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.
![Figure 2 The biofilm formation ability of C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.](/cms/asset/19a2cd4e-07aa-43a2-ac36-22f479ba41c6/didr_a_373991_f0002_c.jpg)
Figure 3 Distribution of the minimum inhibitory concentrations (MICs) of fluconazole among C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.
![Figure 3 Distribution of the minimum inhibitory concentrations (MICs) of fluconazole among C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.](/cms/asset/15728cff-bcb4-4fdc-90d2-fc29f3cd10d3/didr_a_373991_f0003_c.jpg)
Table 1 The MICs, MBICs, and MBECs of Fluconazole Against C. albicans Strains
Figure 4 Inhibitory effect of essential fatty acids (EFAs) on biofilm formation of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).
![Figure 4 Inhibitory effect of essential fatty acids (EFAs) on biofilm formation of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).](/cms/asset/81063563-7f67-4234-94df-76acf9a8d275/didr_a_373991_f0004_c.jpg)
Figure 5 Eradication effect of essential fatty acids (EFAs) on mature biofilm of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).
![Figure 5 Eradication effect of essential fatty acids (EFAs) on mature biofilm of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).](/cms/asset/74c9ec5c-3e82-4800-9326-31e392004a44/didr_a_373991_f0005_c.jpg)
Table 2 The MICs of Fluconazole in Combination with EFAs Against C. albicans Strains
Table 3 The MBICs of Fluconazole in Combination with EFAs Against C. albicans Strains
Table 4 The MBECs of Fluconazole in Combination with EFAs Against C. albicans Strains